FSA wins tribunal case

clock

The FSA has won its case before the Financial Services and Markets Tribunal (the Tribunal) to ban the former CEO of Alternative Solutions (AltSol) from working in the UK financial services industry.

The Tribunal found that Mr Milan Vukelic's actions during August 1999 until October 2002, whilst acting as CEO, lacked integrity. The AltSol business unit was established by the General Reinsurance Corporation to develop and market financial reinsurance products.  The contracts can be misused by struggling insurance companies seeking to disguise their true financial position. The tribunal says during his time as CEO Vukelic was responsible for overseeing and structuring three different transactions designed to allow the client insurance companies to hide very significant losses in their...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Your profession

Feel Good Friday: Quilter pledges £3m towards financial education

Feel Good Friday: Quilter pledges £3m towards financial education

Alongside £1m in grants supporting charities

Professional Adviser
clock 13 February 2026 • 1 min read
Brits unlikely to see IFAs despite Budget impact

Brits unlikely to see IFAs despite Budget impact

Just 19% were likely to seek advice, Continuum finds

Isabel Baxter
clock 12 February 2026 • 3 min read
Treasury consults on AR regime adding further FCA and FOS permissions

Treasury consults on AR regime adding further FCA and FOS permissions

Amid concerns about consumer harm and weaknesses in oversight

Isabel Baxter
clock 12 February 2026 • 3 min read